Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6172717rdf:typepubmed:Citationlld:pubmed
pubmed-article:6172717lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0001924lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0005149lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0023870lld:lifeskim
pubmed-article:6172717lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:6172717pubmed:issue5-6lld:pubmed
pubmed-article:6172717pubmed:dateCreated1982-3-26lld:pubmed
pubmed-article:6172717pubmed:abstractTextAlbumin and beta 2-microglobulin excretions were studied in 85 unselected patients treated with lithium for more than 6 months. In 15 patients a lithium-induced impaired renal concentrating ability was found, 13 of these patients revealed a chronic interstitial nephropathy on renal biopsy. There was no significant increase in albumin excretion, and a markedly increased beta 2-microglobulin excretion was seen in only 1 patient. This study supports the hypothesis that the lithium-induced renal lesion in confirmed to the distal part of the nephron.lld:pubmed
pubmed-article:6172717pubmed:languageenglld:pubmed
pubmed-article:6172717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6172717pubmed:citationSubsetIMlld:pubmed
pubmed-article:6172717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6172717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6172717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6172717pubmed:statusMEDLINElld:pubmed
pubmed-article:6172717pubmed:issn0028-2766lld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:MogensenC ECElld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:HansenH EHElld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:AmdisenAAlld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:SørensenJ LJLlld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:NørgaardKKlld:pubmed
pubmed-article:6172717pubmed:authorpubmed-author:HeilskovJJlld:pubmed
pubmed-article:6172717pubmed:issnTypePrintlld:pubmed
pubmed-article:6172717pubmed:volume29lld:pubmed
pubmed-article:6172717pubmed:ownerNLMlld:pubmed
pubmed-article:6172717pubmed:authorsCompleteYlld:pubmed
pubmed-article:6172717pubmed:pagination229-32lld:pubmed
pubmed-article:6172717pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:meshHeadingpubmed-meshheading:6172717-...lld:pubmed
pubmed-article:6172717pubmed:year1981lld:pubmed
pubmed-article:6172717pubmed:articleTitleAlbumin and beta 2-microglobulin excretion in patients on long-term lithium treatment.lld:pubmed
pubmed-article:6172717pubmed:publicationTypeJournal Articlelld:pubmed